HIPEC surgery for metastatic GI cancer

Sanjay P. Bagaria, M.D., discusses hyperthermic intraperitoneal chemotherapy (HIPEC) surgery for peritoneal carcinomatosis secondary to gastrointestinal (GI) cancers. HIPEC surgery involves removal of all visible cancer in the abdomen ...

Another promising application for stem cells: Crohn's complications

New research at Mayo Clinic is bringing hope to hundreds of thousands of people with Crohn's disease.

Increased gluten avoidance without a celiac diagnosis in the U. S.

Joseph A. Murray, M.D., reveals a surprising trend in which a large portion of the population has independently begun avoiding gluten in their diet, making it extremely challenging for determining accurate trending in the state of celiac disease incidents.

Advances in colorectal cancer screening

Mayo Clinic physicians John B. Kisiel, M.D., and David W. Larson, M.D., M.B.A., discuss the latest advancements in colorectal cancer screening, as well as the latest surgical techniques available for people with colorectal cancer.

FDA approves biosimilar to Humira — IBD in the news

Edward V. Loftus Jr., M.D., discusses some of the issues surrounding this medication, and its potential benefits and drawbacks.

FDA approves of biosimilar to infliximab — IBD in the news

The FDA recently approved a biosimilar (CT-P13) to infliximab, which is used for treating people with IBD, as well as people with rheumatoid arthritis ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.